Whitehawk Therapeutics Inc
General ticker "WHWK" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $219.9M (TTM average)
Whitehawk Therapeutics Inc follows the US Stock Market performance with the rate: 51.9%.
Estimated limits based on current volatility of 2.4%: low 3.65$, high 3.82$
Factors to consider:
- Total employees count: 23 (-42.5%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Early stage limited history, Significant losses, Regulatory and compliance, Capital raising, Third-party risks
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.54$, 3.82$]
- 2026-12-31 to 2027-12-31 estimated range: [1.38$, 3.47$]
Financial Metrics affecting the WHWK estimates:
- Positive: with PPE of 5.5 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: Interest expense per share per price, % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 7.48 > 2.08
- Positive: Inventory ratio change, % of -16.97 <= -3.92
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of 90.37 > 81.92
Short-term WHWK quotes
Long-term WHWK plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $24.35MM | $25.98MM | $7.14MM |
| Operating Expenses | $96.29MM | $93.44MM | $121.55MM |
| Operating Income | $-71.93MM | $-67.46MM | $-114.40MM |
| Non-Operating Income | $6.17MM | $3.77MM | $93.80MM |
| Interest Expense | $0.23MM | $0.15MM | $0.00MM |
| R&D Expense | $48.93MM | $51.03MM | $90.96MM |
| Income(Loss) | $-65.77MM | $-63.69MM | $-20.60MM |
| Net Income(Loss)* | $-65.77MM | $-63.69MM | $-20.60MM |
| Stockholders Equity | $105.19MM | $52.48MM | $136.31MM |
| Inventory | $6.43MM | $5.31MM | $0.00MM |
| Assets | $132.42MM | $70.32MM | $150.83MM |
| Operating Cash Flow | $-59.66MM | $-59.55MM | $-97.43MM |
| Capital expenditure | $3.97MM | $1.65MM | $0.55MM |
| Investing Cash Flow | $83.21MM | $25.20MM | $11.89MM |
| Financing Cash Flow | $0.33MM | $0.13MM | $94.38MM |
| Earnings Per Share** | $-2.44 | $-2.36 | $-0.33 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.